BMY 45778 is a partial agonist at IP prostacyclin receptors that is a non-prostanoid prostacyclin mimetic. BMY 45778 has shown to inhibit platelet aggregation in vitro. References: Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins. 1997 Jan;53(1):21-35. PubMed PMID: 9068064.

纯度：≥98%

CAS：152575-66-1